Satellos Bioscience
Biotechnology ResearchOntario, Canada11-50 Employees
Satellos Bioscience is a Toronto-based biotechnology company focused on regenerative medicine, aiming to treat severe muscle disorders by stimulating or restoring muscle regeneration. The work is grounded in the idea that dysregulated muscle stem-cell polarity disrupts the balance between replenishing stem cells and producing specialized tissue, hindering repair over life. Its lead program targets Duchenne muscular dystrophy with an oral therapy that aims to correct this dysregulation, addressing a root driver of disease progression. Satellos leverages its proprietary discovery platform, MyoReGenX, to map regulatory pathways and identify drug candidates for muscle conditions where stem-cell polarity is dysregulated. Based in Toronto, Ontario, Canada, the company operates as a small biotechnology firm seeking to apply regenerative science to a spectrum of muscle disorders, from rare diseases to broader indications.
1-888-653-2347 
support@leadiq.com 
